RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Clinical trial NCT07269691 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07269691
Sponsor: Pengfei Qiu
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer

Start date: 2025-12-01
Primary completion: 2027-12-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.